The effect of radiation therapy on the objective response and outcomes with nivolumab for hepatocellular carcinoma
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
Acta oncologica (Stockholm, Sweden) - 59(2020), 8 vom: 19. Aug., Seite 940-943 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Smith, William H [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
31YO63LBSN |
|---|
| Anmerkungen: |
Date Completed 28.05.2021 Date Revised 28.05.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/0284186X.2020.1769860 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310238005 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310238005 | ||
| 003 | DE-627 | ||
| 005 | 20231225135648.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/0284186X.2020.1769860 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1034.xml |
| 035 | |a (DE-627)NLM310238005 | ||
| 035 | |a (NLM)32441551 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Smith, William H |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The effect of radiation therapy on the objective response and outcomes with nivolumab for hepatocellular carcinoma |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.05.2021 | ||
| 500 | |a Date Revised 28.05.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antineoplastic Agents, Immunological |2 NLM | |
| 650 | 7 | |a Programmed Cell Death 1 Receptor |2 NLM | |
| 650 | 7 | |a Nivolumab |2 NLM | |
| 650 | 7 | |a 31YO63LBSN |2 NLM | |
| 700 | 1 | |a Law, Amy S |e verfasserin |4 aut | |
| 700 | 1 | |a Hulkower, Miriam |e verfasserin |4 aut | |
| 700 | 1 | |a McGee, Heather M |e verfasserin |4 aut | |
| 700 | 1 | |a Lehrer, Eric J |e verfasserin |4 aut | |
| 700 | 1 | |a Schwartz, Myron |e verfasserin |4 aut | |
| 700 | 1 | |a Taouli, Bachir |e verfasserin |4 aut | |
| 700 | 1 | |a Sung, Max |e verfasserin |4 aut | |
| 700 | 1 | |a Buckstein, Michael |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta oncologica (Stockholm, Sweden) |d 1993 |g 59(2020), 8 vom: 19. Aug., Seite 940-943 |w (DE-627)NLM012619353 |x 1651-226X |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2020 |g number:8 |g day:19 |g month:08 |g pages:940-943 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/0284186X.2020.1769860 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2020 |e 8 |b 19 |c 08 |h 940-943 | ||